USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
APOVAX, INC.
Address:
1044 E CHESTNUT ST
LOUISVILLE, KY
Phone:
N/A
URL:
N/A
EIN:
161139201
DUNS:
140646345
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
STTR Phase I $803,836.00 1

Award List:

ApoFasL as a novel treatment for Type 1 Diabetes in Nonhuman Primates

Award Year / Program / Phase:
2010 / STTR / Phase I
Award Amount:
$803,836.00
Agency:
HHS
Principal Investigator:
Kathryn J. Macleod – 502-212-2493
Research Institution:
University Of Alabama System
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Pancreatic islet transplantation is a viable approach for the treatment of type 1 diabetes (T1D). However, this therapeutic approach suffers from graft rejection. Dr. Shirwan, founder of ApoImmune, has developed a novel immunotherapeutic approach aimed at… More